RESHAPE LIFESCIENCES INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.172 USD | -1.15% |
|
+3.70% | -30.36% |
| May. 15 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 | |
| May. 15 | Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M | MT |
Presenter SpeechJames Salierno (Attendees)Good morning, and thank you for joining the first qu...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Calendar
May. 15
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.174
USD
Average target price
1
USD
Spread / Average Target
+474.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.36% | 4.08M | |
| +12.83% | 229B | |
| +14.57% | 195B | |
| +17.68% | 142B | |
| +29.14% | 109B | |
| +3.27% | 64.85B | |
| +18.35% | 54.33B | |
| +7.63% | 52.09B | |
| +10.98% | 45.15B | |
| +5.75% | 37.39B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- Transcript : ReShape Lifesciences Inc., Q1 2021 Earnings Call, May 18, 2021